Intentions for catch-up HPV vaccination in Japan : an internet survey
© 2023. The Author(s)..
PURPOSE: In Japan, Japan's Ministry of Health, Labor, and Welfare decided to suspend govermental recommendation for HPV vaccination in FY 2013. The HPV vaccination rate for those born in FY 2000 or thereafter declined dramatically. In 2021, the "suspension of recommendation" ended. The catch-up vaccinations for the unvaccinated have been offered nationwide from FY 2022 to FY 2024. We aimed to quantify the vaccination intentions and characteristics of those young women now eligible for catch-up vaccination. METHODS: In February of 2022, we conducted an internet survey targeted women who were born in 1997-2004 but who had not yet been HPV vaccinated.
RESULTS: We received 1,648 valid responses. 41.6% of the respondents wanted to uptake the catch-up HPV vaccination, 29.7% were undecided, and 28.7% did not want to be vaccinated. The intention to uptake catch-up HPV vaccination was associated with a good history of gynecological visits, intention to receive cervical cancer screening, sexual activity, degree of anxiety about cervical cancer, familiarity with problems associated with cervical cancer, experience with vaccination recommendations, and knowledge about cervical cancer (p < 0.05, respectively). In the vaccinated generation, the proportion of the group that did not want to be vaccinated was significantly higher (p < 0.05). In the vaccine-suspended generation, the proportion of the group that wanted to be vaccinated was significantly higher (p < 0.05).
CONCLUSION: Our survey revealed that catch-up vaccination intentions differed depending on the vaccination environment. It is necessary for all organizations involved with HPV vaccination, such as government, medical institutions, and educational institutions, to make recommendations based on an understanding of the characteristics of the "vaccinated generation" and the "vaccine-suspended generation".
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
International journal of clinical oncology - 28(2023), 12 vom: 30. Dez., Seite 1667-1679 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nakagawa, Satoshi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Catch-up vaccination |
|---|
| Anmerkungen: |
Date Completed 01.12.2023 Date Revised 01.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10147-023-02411-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36272315X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36272315X | ||
| 003 | DE-627 | ||
| 005 | 20231226091831.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10147-023-02411-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1209.xml |
| 035 | |a (DE-627)NLM36272315X | ||
| 035 | |a (NLM)37776388 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nakagawa, Satoshi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Intentions for catch-up HPV vaccination in Japan |b an internet survey |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.12.2023 | ||
| 500 | |a Date Revised 01.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a PURPOSE: In Japan, Japan's Ministry of Health, Labor, and Welfare decided to suspend govermental recommendation for HPV vaccination in FY 2013. The HPV vaccination rate for those born in FY 2000 or thereafter declined dramatically. In 2021, the "suspension of recommendation" ended. The catch-up vaccinations for the unvaccinated have been offered nationwide from FY 2022 to FY 2024. We aimed to quantify the vaccination intentions and characteristics of those young women now eligible for catch-up vaccination. METHODS: In February of 2022, we conducted an internet survey targeted women who were born in 1997-2004 but who had not yet been HPV vaccinated | ||
| 520 | |a RESULTS: We received 1,648 valid responses. 41.6% of the respondents wanted to uptake the catch-up HPV vaccination, 29.7% were undecided, and 28.7% did not want to be vaccinated. The intention to uptake catch-up HPV vaccination was associated with a good history of gynecological visits, intention to receive cervical cancer screening, sexual activity, degree of anxiety about cervical cancer, familiarity with problems associated with cervical cancer, experience with vaccination recommendations, and knowledge about cervical cancer (p < 0.05, respectively). In the vaccinated generation, the proportion of the group that did not want to be vaccinated was significantly higher (p < 0.05). In the vaccine-suspended generation, the proportion of the group that wanted to be vaccinated was significantly higher (p < 0.05) | ||
| 520 | |a CONCLUSION: Our survey revealed that catch-up vaccination intentions differed depending on the vaccination environment. It is necessary for all organizations involved with HPV vaccination, such as government, medical institutions, and educational institutions, to make recommendations based on an understanding of the characteristics of the "vaccinated generation" and the "vaccine-suspended generation" | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Catch-up vaccination | |
| 650 | 4 | |a Cervical cancer | |
| 650 | 4 | |a HPV vaccine | |
| 650 | 4 | |a Health communication | |
| 650 | 4 | |a Japan | |
| 650 | 4 | |a Suspension of recommendation | |
| 650 | 7 | |a Papillomavirus Vaccines |2 NLM | |
| 700 | 1 | |a Yagi, Asami |e verfasserin |4 aut | |
| 700 | 1 | |a Ueda, Yutaka |e verfasserin |4 aut | |
| 700 | 1 | |a Ikeda, Sayaka |e verfasserin |4 aut | |
| 700 | 1 | |a Kakuda, Mamoru |e verfasserin |4 aut | |
| 700 | 1 | |a Hiramatsu, Kosuke |e verfasserin |4 aut | |
| 700 | 1 | |a Miyoshi, Ai |e verfasserin |4 aut | |
| 700 | 1 | |a Kimura, Toshihiro |e verfasserin |4 aut | |
| 700 | 1 | |a Hirai, Kei |e verfasserin |4 aut | |
| 700 | 1 | |a Sekine, Masayuki |e verfasserin |4 aut | |
| 700 | 1 | |a Nakayama, Tomio |e verfasserin |4 aut | |
| 700 | 1 | |a Kobayashi, Eiji |e verfasserin |4 aut | |
| 700 | 1 | |a Miyagi, Etsuko |e verfasserin |4 aut | |
| 700 | 1 | |a Enomoto, Takayuki |e verfasserin |4 aut | |
| 700 | 1 | |a Kimura, Tadashi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of clinical oncology |d 1997 |g 28(2023), 12 vom: 30. Dez., Seite 1667-1679 |w (DE-627)NLM095566163 |x 1437-7772 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2023 |g number:12 |g day:30 |g month:12 |g pages:1667-1679 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10147-023-02411-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2023 |e 12 |b 30 |c 12 |h 1667-1679 | ||